<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000306498"><TermName>fulvestrant</TermName><TermPronunciation>(ful-VES-trunt)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat certain types of breast cancer in postmenopausal women. It is also being studied in the treatment of other types of cancer. Fulvestrant blocks estrogen activity in the body and is a type of antiestrogen. Also called Faslodex and ICI 182780.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710172" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fulvestrant&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710171" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fulvestrant&quot;" language="es" id="_4"/><SpanishTermName>fulvestrant</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar ciertos tipos de cáncer de seno (mama) en mujeres posmenopáusicas. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. Fulvestrant bloquea la actividad del estrógeno en el cuerpo; es un tipo de antiestrógeno. También se llama Faslodex y ICI 182780.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-05-23</DateFirstPublished><DateLastModified>2007-07-06</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000491908">Fulvestrant</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
